Treatment of acute myelogenous leukemia in older adults.
about
Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth.Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment.Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of actionIntensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.Targeting leukemia stem cells: The new goal of therapy in adult acute myeloid leukemia.Tipifarnib in the treatment of acute myeloid leukemia.Is there a role for postremission therapy in older adults with acute myelogenous leukemia (AML)?Standard intensive chemotherapy is less effective and far more toxic than attenuated induction and post-induction regimen in elderly patients with acute myeloid leukemia.Acute myeloid leukemia in the elderly: etoposide when anthracyclins are contraindicated.Prognostic risk score for the survival of elderly patients with acute myeloid leukaemia comprising comorbidities.Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial.Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience.
P2860
Q33216322-4C23C4DC-D9F8-43F2-8C00-C7A3CA412565Q34452654-9947FE02-1F2B-4D94-9B4E-919084E093EDQ35047162-49A203D9-0DB2-4B16-B1B9-3D33543258D7Q40138696-E9958A72-5261-4CA8-8314-7849AE702677Q40567029-2D5F9CAF-12EE-4D0A-86D5-B80B36AEA71EQ42118010-BC959461-4CB1-42F8-96F7-89250C15FBE2Q42217527-D32D721A-FD90-456D-8E74-EB31F2E841E1Q43461402-43345CB6-926D-49DA-A78E-6C8A8B5B883AQ44260275-C7741AA1-1977-426E-95BC-25FB14C013F4Q45204192-C35F5CA2-57B5-4F55-8755-3BCD4C9A7B20Q45206762-29AA6312-FFC2-4496-B8D4-C209CA1079ACQ46911781-209820DF-22EA-4E35-9C35-F296D25CF65DQ53474437-9C859137-BA3C-4CC4-8250-2F17EA24DA6D
P2860
Treatment of acute myelogenous leukemia in older adults.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment of acute myelogenous leukemia in older adults.
@ast
Treatment of acute myelogenous leukemia in older adults.
@en
type
label
Treatment of acute myelogenous leukemia in older adults.
@ast
Treatment of acute myelogenous leukemia in older adults.
@en
prefLabel
Treatment of acute myelogenous leukemia in older adults.
@ast
Treatment of acute myelogenous leukemia in older adults.
@en
P356
P1433
P1476
Treatment of acute myelogenous leukemia in older adults.
@en
P2093
P2888
P304
P356
10.1038/SJ.LEU.2401539
P577
2000-03-01T00:00:00Z
P5875
P6179
1046919449